Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Research and Development Grants

University of New Brunswick

$17,566.00

Development of new adsorbent for selective removal of halogenated anesthetics

FY 2014-15

Summary
The company involved in this project, Blue-Zone Technologies from Toronto, has developed a process based on proprietary granulated adsorbent Deltazite? for selective removal and recovery of low concentration halogenated anesthetics coming from hospital operating rooms. During operation only a small amount of the administered anesthetic, i.e., less than 5% is metabolized by the patient. The remaining 95% either escapes or is vented through hospital ventilation systems unabated directly into the atmosphere. These vapors are considered aggressive greenhouse gases with the Global Warming Potential (GWP) up to 3,766 times higher than for the CO2 and have a 20 year impact. Since these anesthetics are valuable commodities (costing up to $1,200 per liter) the Deltasorb? adsorbent, with captured anesthetics, is regenerated by thermal desorption and then adsorbates liquefied into halogenated condensate. The liquefied condensate is a mix of all three anesthetics and is used as a feedstock for the next process, e.g., Blue-Zone proprietary fractional distillation process, where each component is isolated, separated and purified to meet or exceed the USP anesthetic drug medical standards. Even though the Blue-Zone process has been successfully applied in a number of hospitals in Canada (mainly Toronto area) and USA, the company would like to improve the process and make it more marketable throughout North America and possibly globally. To accomplish this, a new process is essential to be developed by focusing on the development of new adsorbent material, e.g., silica based hydrophobic adsorbent. This material should have better selectivity and adsorption capacity in the presence of water vapor, which is a part of the scavanged gas coming from operating rooms, in comparison to the current Deltasorb adsorbent. The company plans to develop the new material in collaboration with the researech group from University of New Brunswick, led by Dr. Mladen Eic. Dr.Eic's group has 28 years of research experience in the area of adsorption in nanoporous materials, from synthesis and characterization to process design and industrial applications.
Program
Collaborative Research and Development Grants
Location
New Brunswick, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
451224-2013
Name nom
Eic, Mladen
Department département
Chemical Engineering
Organization id
75
Institution établissement
University of New Brunswick
Province en
New Brunswick
Province fr
Nouveau-Brunswick
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2013
Award amount
17566
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
602
Area of application group en
Construction, urban and rural planning
Area of application group fr
Construction, urbanisme et aménagement rural
Area of application en
Materials performance
Area of application fr
Performance des matériaux
Research subject code
1806
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Separation processes
Research subject fr
Procédés de séparation
Partie
2
Nb partie
2
Application title
Development of new adsorbent for selective removal of halogenated anesthetics
Keyword
NSERC
Application summary
The company involved in this project, Blue-Zone Technologies from Toronto, has developed a process based on proprietary granulated adsorbent Deltazite? for selective removal and recovery of low concentration halogenated anesthetics coming from hospital operating rooms. During operation only a small amount of the administered anesthetic, i.e., less than 5% is metabolized by the patient. The remaining 95% either escapes or is vented through hospital ventilation systems unabated directly into the atmosphere. These vapors are considered aggressive greenhouse gases with the Global Warming Potential (GWP) up to 3,766 times higher than for the CO2 and have a 20 year impact. Since these anesthetics are valuable commodities (costing up to $1,200 per liter) the Deltasorb? adsorbent, with captured anesthetics, is regenerated by thermal desorption and then adsorbates liquefied into halogenated condensate. The liquefied condensate is a mix of all three anesthetics and is used as a feedstock for the next process, e.g., Blue-Zone proprietary fractional distillation process, where each component is isolated, separated and purified to meet or exceed the USP anesthetic drug medical standards. Even though the Blue-Zone process has been successfully applied in a number of hospitals in Canada (mainly Toronto area) and USA, the company would like to improve the process and make it more marketable throughout North America and possibly globally. To accomplish this, a new process is essential to be developed by focusing on the development of new adsorbent material, e.g., silica based hydrophobic adsorbent. This material should have better selectivity and adsorption capacity in the presence of water vapor, which is a part of the scavanged gas coming from operating rooms, in comparison to the current Deltasorb adsorbent. The company plans to develop the new material in collaboration with the researech group from University of New Brunswick, led by Dr. Mladen Eic. Dr.Eic's group has 28 years of research experience in the area of adsorption in nanoporous materials, from synthesis and characterization to process design and industrial applications.
University of New Brunswick - $17,566 Grant (2014-15) | Canada Spends